Business
Result of WRAP Retail Offer
Result of WRAP Retail Offer.
About this update from Oxford Biodynamics Plc
[{"type":"text","content":"\n\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, SOUTH AFRICA OR JAPAN, OR ANY MEMBER STATE OF THE EEA, OR ANY OTHER JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.\n \nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 WHICH FORMS PART OF THE LAWS OF ENGLAND AND WALES PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (\"UK MAR\"). UPON PUBLICATION OF THIS ANNOUNCEMENT THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE WITHIN THE PUBLIC DOMAIN.\n \n \nOxford BioDynamics plc\n \n(\"Oxford BioDynamics\" or the \"Company\")\n \nResult of WRAP Retail Offer\n \nOxford, UK - 17 January 2025 - Oxford Biodynamics plc, (AIM: OBD), a precision clinical diagnostics company bringing specific and sensitive tests to the practice of medicine based on OBD's EpiSwitch® 3D genomics platform, is pleased to confirm, further to the announcements made on 14 and 15 January 2025, the result of its Fundraise at the Issue Price of 0.5 pence per share. The Company announces that it has raised gross proceeds of approximately £350,000 pursuant to the WRAP Retail Offer, in addition to the £7 million raised through the Placing and Subscriptions announced on 15 January 2025. Accordingly, the Company will issue 70,002,778 new Ordinary Shares at the Issue Price pursuant to the WRAP Retail Offer.\n \nIn total, the Fundraising has raised gross proceeds of approximately £7.35 million for the Company, via the issue of 988,625,012 Placing Shares, 411,374,988 Subscription Shares and 70,002,778 WRAP Offer Shares.\n \nAdmission and settlement\nAn application will be made to the London Stock Exchange for the new Ordinary Shares to be admitted to trading on AIM. It is expected that General Admission will become effective and dealings in the new Ordinary Shares to be issued pursuant to the General Placing, the General Subscription and the WRAP Retail Offer will commence on 4 February 2025, subject to the approval by the Company's shareholders of the resolutions to be proposed at a general meeting o...